INTELLIA THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
INTELLIA THERAPEUTICS, INC. (NTLA) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$3.19 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2023-02-23
- INTELLIA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-03-31 was -$5.43M.
- INTELLIA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-09-30 was -$161.00K.
- INTELLIA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-06-30 was -$1.00K.
- INTELLIA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-03-31 was -$13.00K, a 111.61% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$3.19M.
- INTELLIA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was -$507.00K.
- INTELLIA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2020 was -$260.00K, a 189.97% decline from fiscal 2019.
- INTELLIA THERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2019 was $289.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$3.19M 10-K · filed 2023-02-23 | |||
| 2022-03-31 | -$5.43M 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | -$507.00K 10-K · filed 2023-02-23 | |||
| 2021-09-30 | -$161.00K 10-Q · filed 2022-11-03 | -$162.00K derived: sum of 2 quarters · filed 2022-11-03 | -$175.00K derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | -$1.00K 10-Q · filed 2021-11-04 | -$14.00K derived: sum of 2 quarters · filed 2022-05-05 | ||
| 2021-03-31 | -$13.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$260.00K 10-K · filed 2021-02-26 | |||
| 2020-09-30 | -$124.00K 10-Q · filed 2021-11-04 | -$342.00K derived: sum of 2 quarters · filed 2021-11-04 | -$230.00K derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | -$218.00K 10-Q · filed 2021-11-04 | -$106.00K derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $112.00K 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $289.00K 10-K · filed 2021-02-26 | |||
| 2019-09-30 | $81.00K 10-Q · filed 2020-11-05 | $277.00K derived: sum of 2 quarters · filed 2020-11-05 | $364.00K derived: sum of 3 quarters · filed 2020-11-05 | |
| 2019-06-30 | $196.00K 10-Q · filed 2020-11-05 | $283.00K derived: sum of 2 quarters · filed 2020-11-05 | ||
| 2019-03-31 | $87.00K 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | -$28.00K 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |